These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2983076)

  • 21. Constrained search of conformational hyperspace.
    Dammkoehler RA; Karasek SF; Shands EF; Marshall GR
    J Comput Aided Mol Des; 1989 Mar; 3(1):3-21. PubMed ID: 2715794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Domain-selective ligand-binding modes and atomic level pharmacophore refinement in angiotensin I converting enzyme (ACE) inhibitors.
    Tzakos AG; Gerothanassis IP
    Chembiochem; 2005 Jun; 6(6):1089-103. PubMed ID: 15883972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and design of specific inhibitors of angiotensin-converting enzyme.
    Cushman DW; Cheung HS; Sabo EF; Ondetti MA
    Am J Cardiol; 1982 Apr; 49(6):1390-4. PubMed ID: 6176105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of a lipophilic captopril analogue binding to angiotensin I converting enzyme.
    Dalkas GA; Marchand D; Galleyrand JC; Martinez J; Spyroulias GA; Cordopatis P; Cavelier F
    J Pept Sci; 2010 Feb; 16(2):91-7. PubMed ID: 20014331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New potent inhibitors of angiotensin converting enzyme.
    Attwood MR; Francis RJ; Hassall CH; Kröhn A; Lawton G; Natoff IL; Nixon JS; Redshaw S; Thomas WA
    FEBS Lett; 1984 Jan; 165(2):201-6. PubMed ID: 6319181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
    Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
    Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of angiotensin I-converting enzyme.
    Sturrock ED; Natesh R; van Rooyen JM; Acharya KR
    Cell Mol Life Sci; 2004 Nov; 61(21):2677-86. PubMed ID: 15549168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera.
    Williams TA; Barnes K; Kenny AJ; Turner AJ; Hooper NM
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):875-81. PubMed ID: 1335236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril.
    Kim HM; Shin DR; Yoo OJ; Lee H; Lee JO
    FEBS Lett; 2003 Mar; 538(1-3):65-70. PubMed ID: 12633854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Configuration and preferential solid-state conformations of perindoprilat (S-9780). Comparison with the crystal structures of other ACE inhibitors and conclusions related to structure-activity relationships.
    Pascard C; Guilhem J; Vincent M; Rémond G; Portevin B; Laubie M
    J Med Chem; 1991 Feb; 34(2):663-9. PubMed ID: 1995891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide inhibitors and the active site(s) of angiotensin converting enzyme.
    Riordan JF; Chen YN; Kleemann SG; Bünning P
    Biomed Biochim Acta; 1991; 50(4-6):809-14. PubMed ID: 1666286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L -proline a novel orally active inhibitor of ACE.
    Karanewsky DS; Badia MC; Cushman DW; DeForrest JM; Dejneka T; Loots MJ; Perri MG; Petrillo EW; Powell JR
    J Med Chem; 1988 Jan; 31(1):204-12. PubMed ID: 3336020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The design of a new group of angiotensin-converting enzyme inhibitors.
    Hassall CH; Kröhn A; Moody CJ; Thomas WA
    FEBS Lett; 1982 Oct; 147(2):175-9. PubMed ID: 6293868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of domain-selective angiotensin I-converting enzyme inhibitors.
    Redelinghuys P; Nchinda AT; Sturrock ED
    Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method.
    Andújar-Sánchez M; Jara-Pérez V; Cámara-Artigas A
    FEBS Lett; 2007 Jul; 581(18):3449-54. PubMed ID: 17618628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory profiles of captopril on matrix metalloproteinase-9 activity.
    Yamamoto D; Takai S; Miyazaki M
    Eur J Pharmacol; 2008 Jul; 588(2-3):277-9. PubMed ID: 18501888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.